Cipla receives EIR from USFDA

Cipla receives EIR from USFDA

by admin- Monday, January 20th, 2020 03:45:45 PM

Cipla has introduced that the inspection via the United States Food and Drug Administration (USFDA) at the Patalganga production facility of the Company from
November 4, 2019 to November 13, 2019, the Company has obtained the Establishment Inspection Report (EIR), indicating closure of the inspection.

News Updates